3834-86-4

Basic information

• Product Name: Cyclohexanone, 2-(4-pentenyl)-
• CAS NO: 3834-86-4
• Molecular Formula: C11H18O
• Molecular Weight: 166.263
• Mol File: 3834-86-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Cyclohexanone, 2-(4-pentenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanone, 2-(4-pentenyl)-(3834-86-4)
• EPA Substance Registry System: Cyclohexanone, 2-(4-pentenyl)-(3834-86-4)

Safety Data

• Hazardous Substances Data: 3834-86-4(Hazardous Substances Data)

Upstream product

• 1125-99-1 1-(1-Cyclohexen-1-yl)pyrrolidine 
• 628-77-3 1,5-diiodopentane 
• 108-94-1 cyclohexanone 
• 1119-51-3 bromopentene 

Downstream Products

• 1111165-86-6 acetic acid 1-ethynyl-2-pent-4-enyl-cyclohexyl ester 
• 396080-19-6 C₁₁H₁₉NO 
• 22627-54-9 2--cyclohexan-carbaldehyd 
• 3643-57-0 2-(Penta-4-enyliden)-cyclohexan-1-on 
• 22627-53-8 1-Ethoxymethyl-2--cyclohexanol 
• 70298-95-2 (2-pent-4-enyl-cyclohexylidene)-methyl-amine oxide 
• 65727-66-4 2-methylbicyclo<4.4.0.>decan-1-ol 
• 65727-68-6 2-(4-Pentenyl)-cyclohexanol 
• 67820-64-8 2--1-acetoxy-cyclohexen-(1) 

Relevant articles and documents

Oxidative cyclization reactions: Controlling the course of a radical cation-derived reaction with the use of a second nucleophile

Construction of new ring systems: Oxidative cyclizations (see picture; RVC=reticulated vitreous carbon) have been conducted that use two separate intramolecular nucleophiles to trap an enol ether-derived radical cation intermediate. The reactions provide

Gold- Vs. platinum-catalyzed polycyclizations by O-acyl migration. solvent-free reactions

Polycyclic derivatives incorporating a cyclopropyl group have been efficiently synthesized from propargyl acetates using platinum(II), gold(I) and gold(III) catalysis. These reactions which are also viable for the preparation of medium-sized rings, proceed with a complete diastereocontrol and can also be run in neat conditions.

METHODS FOR TREATMENT AND PREVENTION OF GASTROINTESTINAL CONDITIONS

Therapeutic methods for the prevention ad treatment of conditions and diseases of the gastrointestinal tract involving an overproduction of nitric oxide by inducible nitric oxide synthase are described, the methods including administering to a subject in need thereof a therapeutically effective amount of a selective inhibitor of inducible nitric oxide synthase (iNOS). The methods also include the use of selective inhibitors of iNOs in combination with other therapeutic agents, including antimicrobial agents and antisecretory agents.